Elusys receives second delivery order from U.S. government for Anthim®, its treatment for Inhalation Anthrax

Media Center PRESS RELEASE 2018 ELUSYS RECEIVES SECOND DELIVERY ORDER FROM U.S. GOVERNMENT FOR ANTHIM®, ITS TREATMENT FOR INHALATION ANTHRAX Elusys receives $19.7 million for delivery of ANTHIM under first Delivery Order PINE BROOK, NJ, April 23, 2018 – Elusys Therapeutics, Inc. (Elusys) announced today that it has been awarded a $25.2 million follow-on Delivery […]